论文部分内容阅读
我院应用常州生物化学制药厂生产的胰激肽释放酶片治疗糖尿病微量白蛋白尿及糖尿病肾病患者20例，现报道如下。资料和方法1．一般资料：所有病例均选自住院病人，随机分为两组，对照组20例，治疗组20例。根据1985年WHO糖尿病诊断标准和1994年美国糖尿病协会（ADA）以及国家肾病
Our hospital application of Changzhou biochemical pharmaceutical production of kallikrein tablets for the treatment of diabetic microalbuminuria and diabetic nephropathy in 20 patients are reported below. Data and methods 1. General information: All cases were selected from hospitalized patients, were randomly divided into two groups, the control group of 20 patients, the treatment group of 20 patients. According to the 1985 WHO diagnostic criteria for diabetes and the 1994 American Diabetes Association (ADA) and national renal disease